Strive Health, Oak Street Health kick off multiyear partnership on kidney care

Kidney care startup Strive Health is teaming up with Oak Street Health, a primary care provider focused on Medicare, to deliver specialized care for people with chronic kidney disease.

The multiyear collaboration will target people with stage 4 chronic kidney disease through end-stage kidney disease across the 21 states in which Oak Street Health operates. Strive Health will bolster Oak Street providers with resources needed to help patients delay the progression of their disease.

The collaboration reflects both companies’ goal to rebuild and transform healthcare through innovative care models focused on quality over quantity of services.

“We focus on delivering compassionate kidney care and Oak Street Health offers the best clinical care model for older adults, so bringing the organizations together in collaboration is a natural fit,” Will Stokes, co-founder and chief strategy officer at Strive, said in a press release. 

Strive’s CareMultiplier technology gathers data from hundreds of sources for a holistic view of a patient’s experience. Those data help care teams understand a patient’s risk of hospitalization or progression of the disease, enabling more tailored care. The tech paired with Strive’s interdisciplinary care team integrates nephrology partners to help drive better outcomes and close care gaps.

“Strive is the right fit as we look to provide this additional comprehensive care to our late-stage [chronic kidney disease] and [end-stage kidney disease] patients that we serve at our centers,” Drew Crenshaw, chief population health officer at Oak Street Health, said in the press release. “We went through a robust search process and were impressed with Strive’s care model. The strong alignment with their clinical approach, as well as our geographic overlap made it a natural choice.”

Through its partnerships with health systems, medical groups, individual providers and payers, Strive manages 100,000 complex chronic and end-stage kidney disease patients across 30 states.